Episode 3: DCIS and Low-Risk, Early-Stage Breast Cancer Part 2

Drs Lidia Schapira and Antonio Wolff resume their discussion about the current research on DCIS and other forms of lower-risk early breast cancer, and how medical oncologists can work to create an optimal treatment plan.

Related Keywords

Lidia Schapira ,Melanie Royce ,Johns Hopkins ,Antonio Wolff , ,Breast Cancer ,Alignant Breast Neoplasm ,Her2 Positive Breast Cancer ,Her2 Breast Cancer ,Estrogen Receptor Positive Breast Carcinoma ,Tamoxifen ,Elective Estrogen Receptor Modulator Serm ,Metastasis ,Cancer Risk ,Endocrine Therapy ,Hormone Therapy ,Clinical Research ,Clinical Trials ,Linical Studies ,Us Food And Drug Administration ,Nited States Food And Drug Administration ,Fda ,Healthcare And Me ,